| |
| |
|
| Insider
Information: |
Yarema Kristin |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
778,251 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,410,837 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
778,251 |
|
|
| Total
Value |
$1,410,837 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
|
2022-03-01 |
171,415 |
2020-03-01 |
0 |
Premium* |
|
|
Poseida Therapeutics, Inc. |
PSTX |
|
2024-01-02 |
606,836 |
2023-04-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PSTX |
Poseida Therapeutics, Inc... |
President and CEO |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
606,836 |
0 |
- |
|
| PSTX |
Poseida Therapeutics, Inc... |
President, Cell Therapy |
• – – |
2023-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
356,836 |
356,836 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Commercial Officer |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,533 |
171,415 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Commercial Officer |
• – – |
2021-06-14 |
4 |
B |
$14.48 |
$471,065 |
D/D |
32,333 |
125,882 |
2.74 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Commercial Officer |
• – – |
2021-06-11 |
4 |
B |
$14.50 |
$29,305 |
D/D |
2,021 |
93,549 |
2.74 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Commercial Officer |
• – – |
2021-05-18 |
4 |
AS |
$14.55 |
$11,073 |
D/D |
(761) |
91,528 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Commercial Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,021 |
92,289 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Commercial Officer |
• – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
55,000 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
